According to Biodesix's latest financial reports the company's current revenue (TTM ) is โน6.48 Billion. In 2024 the company made a revenue of โน6.11 Billion an increase over the revenue in the year 2023 that were of โน4.08 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | โน6.30 B | 3.02% |
2024 | โน6.11 B | 49.73% |
2023 | โน4.08 B | 29.23% |
2022 | โน3.16 B | -22.06% |
2021 | โน4.05 B | 21.77% |
2020 | โน3.33 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() OpGen
OPGN | โน0.11 B | -98.30% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | โน58.54 B | 802.95% | ๐บ๐ธ USA |
![]() LabCorp LH | โน1.147 T | 17,596.57% | ๐บ๐ธ USA |